A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia

NCT00922389 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot
Critical Limb Ischemia
Leg Ulcers

Interventions

PROCEDURE: will receive G-CSF and peripheral blood derived mononuclear cells
DRUG: G-CSF
DRUG: Standard Therapy

Sponsor

Beike Biotech India Pvt.ltd